NDC11 13913000812
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 13913-0008-12 | 13913-0008 |
| 13913-008-12 | 13913-008 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZIPSOR | DICLOFENAC POTASSIUM | Assertio Therapeutics, Inc. | c982eca0-fc41-11e1-a9c8-0002a5d5c51b | 2025-09-03 | Boxed warning, Warnings, Adverse reactions | 13913-008-12 13913-008 13913000812 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.